Zobrazeno 1 - 10
of 83
pro vyhledávání: ''
Publikováno v:
Anticancer Research. 42:1001-1006
Formation of stoma during cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis (PC) is often performed to reduce the risk of anastomotic leak. Subsequent stoma reversal provides a unique oppo
Autor:
Hajime, Imamura, Tomohiko, Adachi, Takayuki, Tanaka, Hajime, Matsushima, Takanobu, Hara, Akihiko, Soyama, Masaaki, Hidaka, Susumu, Eguchi
Publikováno v:
Anticancer Research. 42:903-910
The laparoscopic approach is not widely used for gallbladder tumours because of the high degree of malignancy associated with gallbladder cancer and technical difficulties. This study aimed to clarify the feasibility and safety of laparoscopic gallbl
Autor:
Yukihiro, Hama, Etsuko, Tate
Publikováno v:
Anticancer Research. 42:329-334
This study investigated the feasibility and efficacy of multiparametric magnetic resonance imaging (MRI)-guided dose-escalated hypofractionated intensity-modulated radiation therapy with simultaneous integrated boost (IMRT-SIB) for glioblastoma.Eight
Autor:
Takahiro Kojima, Kazutoshi Yamana, Hayato Yamamoto, Tomokazu Sazuka, Shohei Fukuda, Noboru Nakaigawa, Hiroshi Murakami, Renpei Kato, Wataru Obara, Shuzo Hamamoto, Yusuke Sugino, Koki Kabu
Publikováno v:
Anticancer Research. 41:6199-6209
Background/aim To evaluate the effectiveness and safety of nivolumab plus ipilimumab for untreated metastatic renal cell carcinoma in real-world clinical practice in Japan based on 1-year follow-up results. Patients and methods This multicentre, retr
Autor:
Denisa Rozsivalova, Jana Alahakoon, Juraj Kultan, Andrea Mullerova, Kristián Brat, Daniel Krejci, Ondrej Venclicek, Libor Havel, Martin Svaton, Martina Vasakova, Petra Smickova, Ondrej Fischer, Kristyna Hrda, Jana Skrickova, Zsuzsanna Gyorfy, Miloslav Marel, Gabriela Krakorova, P. Opálka, Michal Hrnčiarik, Jaroslav Duba, Jiri Silar, Michal Svoboda, Michal Jirousek, Petr Zuna, J. Krejčí, Lydia Zarnayova
Publikováno v:
Anticancer Research. 41:5549-5556
Background/aim LUCAS is a clinical lung cancer registry (ClinicalTrials.gov identifier is NCT04228237), prospectively collecting data from newly diagnosed lung cancer patients in seven pneumooncology centers in the Czech Republic, since June 1, 2018.
Autor:
Ya-Wen Ho, Chang-Hsien Lu, Chen-Kan Tseng, Wen-Chi Chou, Yung-Hsin Huang, Chieh Yang, Yu-Shin Hung, Ngan-Ming Tsang, Cheng-Chou Lai, Shun-Wen Hsueh, Pei-Hung Chang, Chia-Yen Hung, Ming-Mo Ho, Kun-Yun Yeh, Yu-Ching Lin
Publikováno v:
Anticancer Research. 41:5213-5222
BACKGROUND/AIM The clinical significance of frailty status on treatment outcome in patients with esophageal cancer (EC) has been seldom explored. This study aimed to evaluate the impact of pretreatment frailty on treatment-related toxicity and surviv
Publikováno v:
Anticancer Research. 41:5001-5006
Background/aim To describe clinical features, radiotherapy (RT), and symptom outcomes in cancer patients with cranial nerve palsies associated with clival metastases. Patients and methods This is a retrospective review of patients with primary metast
Autor:
Teruhisa Sakamoto, Yoichiro Tada, Shuichi Takano, Wataru Miyauchi, Kyoichi Kihara, Kazushi Hara, Toshimichi Hasegawa, Yoshiaki Matsumi, Ken Sugesawa, Manabu Yamamoto, Yoshiyuki Fujiwara, Yuji Nakayama, Akimitsu Tanio, Chihiro Uejima
Publikováno v:
Anticancer Research. 41:4857-4865
Background/aim M1 macrophages have antitumour effects, while M2 macrophages promote tumour proliferation and invasion. The clinical significance of the M2-specific marker CD204 has not been elucidated in colorectal cancer (CRC). We investigated the p
Autor:
Hideo Baba, Taishi Yamane, Shinya Shimada, Kei Horino, Daisuke Izumi, Chika Shirakami, Keisuke Morita, Satoshi Ikeshima, Shotaro Kinoshita
Publikováno v:
Anticancer Research. 41:5223-5229
AIM The aim of the current study was to investigate whether the artery-first approach (AFA) improved surgical outcomes of pancreaticoduodenectomy (PD) at our non-high-volume center. PATIENTS AND METHODS We retrospectively reviewed data on 121 consecu
Autor:
Takahiko Nakamura, Kenjiro Tsuruoka, Kiyoe Kanaoka, Yosuke Tamura, Yasuhito Fujisaka, Soichiro Ikeda, Tomoya Funamoto, Masafumi Imanishi, Isao Goto, Akihisa Imagawa, Hiroyuki Tsuji, Sho Mitsuya, Ninso Matsunaga
Publikováno v:
Anticancer Research. 41:5137-5145
BACKGROUND For epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC), administration of EGFR tyrosine kinase inhibitors (TKIs) is mandatory to prolong survival. To date, a comparison of second- and third-generation EGFR-T